These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
775 related items for PubMed ID: 19524974
1. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy. Bañez LL, Sun L, Trock BJ, Han M, Partin AW, Aronson WJ, Terris MK, Presti JC, Kane CJ, Amling CL, Moul JW, Freedland SJ. J Urol; 2009 Aug; 182(2):491-6; discussion 496-8. PubMed ID: 19524974 [Abstract] [Full Text] [Related]
2. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy? Loeb S, Yu X, Nadler RB, Roehl KA, Han M, Hawkins SA, Catalona WJ. J Urol; 2007 Jan; 177(1):102-6; discussion 106. PubMed ID: 17162013 [Abstract] [Full Text] [Related]
3. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base. Freedland SJ, Kane CJ, Presti JC, Terris MK, Amling CL, Dorey F, Aronson WJ. J Urol; 2003 Mar; 169(3):969-73. PubMed ID: 12576824 [Abstract] [Full Text] [Related]
4. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. Freedland SJ, Sun L, Kane CJ, Presti JC, Terris MK, Amling CL, Moul JW, Aronson WJ. BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175 [Abstract] [Full Text] [Related]
5. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC. Cancer; 2003 Dec 01; 98(11):2344-50. PubMed ID: 14635068 [Abstract] [Full Text] [Related]
6. Impact of patient age on biochemical recurrence rates following radical prostatectomy. Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML. J Urol; 2007 Nov 01; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723 [Abstract] [Full Text] [Related]
7. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database. King CR, Freedland SJ, Terris MK, Kane CJ, Amling CL, Aronson WJ, Presti JC. Urology; 2007 May 01; 69(5):921-6. PubMed ID: 17482935 [Abstract] [Full Text] [Related]
8. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10. Bastian PJ, Gonzalgo ML, Aronson WJ, Terris MK, Kane CJ, Amling CL, Presti JC, Mangold LA, Humphreys E, Epstein JI, Partin AW, Freedland SJ. Cancer; 2006 Sep 15; 107(6):1265-72. PubMed ID: 16900523 [Abstract] [Full Text] [Related]
9. Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database. Moreira DM, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ. J Urol; 2009 Nov 15; 182(5):2250-5. PubMed ID: 19758614 [Abstract] [Full Text] [Related]
10. Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men? Lee SE, Lee WK, Jeong MS, Abdullajanov M, Kim DS, Park HZ, Jeong SJ, Yoon CY, Byun SS, Choe G, Hong SK. BJU Int; 2011 Apr 15; 107(8):1250-5. PubMed ID: 20880194 [Abstract] [Full Text] [Related]
11. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy. Magheli A, Rais-Bahrami S, Peck HJ, Walsh PC, Epstein JI, Trock BJ, Gonzalgo ML. J Urol; 2007 Oct 15; 178(4 Pt 1):1311-5. PubMed ID: 17698095 [Abstract] [Full Text] [Related]
12. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. Freedland SJ, Grubb KA, Yiu SK, Humphreys EB, Nielsen ME, Mangold LA, Isaacs WB, Partin AW. J Urol; 2005 Sep 15; 174(3):919-22. PubMed ID: 16093988 [Abstract] [Full Text] [Related]
13. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy. Suekane S, Noguchi M, Nakashima O, Yamada S, Kojiro M, Matsuoka K. Int J Urol; 2007 Aug 15; 14(8):713-8. PubMed ID: 17681061 [Abstract] [Full Text] [Related]
14. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml. Makarov DV, Humphreys EB, Mangold LA, Walsh PC, Partin AW, Epstein JI, Freedland SJ. J Urol; 2006 Aug 15; 176(2):554-8. PubMed ID: 16813888 [Abstract] [Full Text] [Related]
15. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy. Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML. J Urol; 2007 Oct 15; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121 [Abstract] [Full Text] [Related]
16. Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database. Buschemeyer WC, Hamilton RJ, Aronson WJ, Presti JC, Terris MK, Kane CJ, Amling CL, Freedland SJ. J Urol; 2008 Jan 15; 179(1):124-9; discussion 129. PubMed ID: 17997433 [Abstract] [Full Text] [Related]
17. Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database. Chang SL, Freedland SJ, Terris MK, Aronson WJ, Kane CJ, Amling CL, Presti JC. Urology; 2010 Feb 15; 75(2):439-44. PubMed ID: 19819536 [Abstract] [Full Text] [Related]
18. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database. Freedland SJ, Hotaling JM, Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL. Eur Urol; 2008 Apr 15; 53(4):758-64; discussion 765-6. PubMed ID: 17868976 [Abstract] [Full Text] [Related]
19. Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy. Tomaszewski JJ, Chen YF, Bertolet M, Ristau BT, Woldemichael E, Nelson JB. Urology; 2013 May 15; 81(5):992-6. PubMed ID: 23453649 [Abstract] [Full Text] [Related]
20. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer. Kositsawat J, Flanigan RC, Meydani M, Choi YK, Freeman VL. J Urol; 2007 Dec 15; 178(6):2391-6; discussion 2396. PubMed ID: 17936811 [Abstract] [Full Text] [Related] Page: [Next] [New Search]